Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs
収録刊行物
-
- Arthritis Rheum.
-
Arthritis Rheum. 58 2968-2980, 2008